hMENA11a contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells
Paola Trono, Paola Nisticò(National Cancer Institute)
Cited by 17
Related Papers
Polyfunctional Melan-A-specific tumor-reactive CD8<sup>+</sup>T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS
|OncoImmunology|2016|43
The actin modulator hMENA regulates GAS6‐AXL axis and pro‐tumor cancer/stromal cell cooperation
|EMBO Reports|2020|36
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome
|OncoImmunology|2016|27
Mesenchymal traits at the convergence of tumor-intrinsic and -extrinsic mechanisms of resistance to immune checkpoint blockers
|Emerging Topics in Life Sciences|2017|6